The treatment of patients with polycystic ovaries undergoing IVF.
Franks
S
S
Department of Obstetrics and Gynaecology, Imperial College School of Medicine, St. Mary's, London, England.
D004622:Embryo, Mammalian / Q000502:physiology; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods* / Q000706:statistics & numerical data; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007986:Luteinizing Hormone / Q000378:metabolism*; D008596:Menotropins / Q000627:therapeutic use; D016471:Ovarian Hyperstimulation Syndrome / Q000378:metabolism / Q000517:prevention & control*; D010062:Ovulation Induction; D010063:Ovum / Q000187:drug effects / Q000502:physiology; D011085:Polycystic Ovary Syndrome / Q000378:metabolism* / Q000628:therapy; D011247:Pregnancy; D018873:Pregnancy Rate
D007987:Gonadotropin-Releasing Hormone; D008596:Menotropins; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone